Evidence map›Paper›PMID 24401655›Full record

ArticlePrion

The metazoan protein disaggregase and amyloid depolymerase system: Hsp110, Hsp70, Hsp40, and small heat shock proteins.

Mariana P Torrente, James Shorter

Open access · hybridAbstract read
In one paragraph

Article in Prion. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Microorganisms · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. (Dis)Solving the problem of aberrant protein states.Disease models & mechanisms · 2021
    Review
  13. Article
  14. Combating deleterious phase transitions in neurodegenerative disease.Biochimica et biophysica acta. Molecular cell research · 2021
    Review
  15. Article
  16. Review
  17. Reversal of Alpha-Synuclein Fibrillization by Protein Disulfide Isomerase.Frontiers in cell and developmental biology · 2020
    Article
  18. Review
  19. Review
  20. Spiraling in Control: Structures and Mechanisms of the Hsp104 Disaggregase.Cold Spring Harbor perspectives in biology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Mariana P TorrenteDepartment of Biochemistry and Biophysics; 805b Stellar-Chance Laboratories; Perelman School of Medicine; University of Pennsylvania; Philadelphia, PA USA.
James ShorterDepartment of Biochemistry and Biophysics; 805b Stellar-Chance Laboratories; Perelman School of Medicine; University of Pennsylvania; Philadelphia, PA USA.
University of Pennsylvania · US

Funding

University of Pennsylvania Postdoctoral Opportunities in Research and TeachingK12GM081259 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Janis K. Burkhardt · 2007 to 2026
$20.1M
Defining the mechanistic basis of a prion disaggregaseR01GM099836 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI SHORTER, JAMES · 2013 to 2024
$3.9M
Amyloid elimination by Hsp104 and substrate-optimized variantsDP2OD002177 · OD · UNIVERSITY OF PENNSYLVANIA · PI SHORTER, JAMES · 2007 to 2007
$2.4M
Generating SEVI disaggregases to prevent HIV infectionR21HD074510 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI SHORTER, JAMES · 2012 to 2013
$430k
NICHD NIH HHS R21 HD074510NICHD NIH HHS R21HD074510NIGMS NIH HHS K12 GM081259NIGMS NIH HHS K12GM081259NIGMS NIH HHS R01 GM099836NIGMS NIH HHS R01GM099836NIH HHS DP2 OD002177NIH HHS DP2OD002177
6 · The paper itself

Abstract

A baffling aspect of metazoan proteostasis is the lack of an Hsp104 ortholog that rapidly disaggregates and reactivates misfolded polypeptides trapped in stress induced disordered aggregates, preamyloid oligomers, or amyloid fibrils. By contrast, in bacteria, protozoa, chromista, fungi, and plants, Hsp104 orthologs are highly conserved and confer huge selective advantages in stress tolerance. Moreover, in fungi, the amyloid remodeling activity of Hsp104 has enabled deployment of prions for various beneficial modalities. Thus, a longstanding conundrum has remained unanswered: how do metazoan cells renature aggregated proteins or resolve amyloid fibrils without Hsp104? Here, we highlight recent advances that unveil the metazoan protein-disaggregase machinery, comprising Hsp110, Hsp70, and Hsp40, which synergize to dissolve disordered aggregates, but are unable to rapidly solubilize stable amyloid fibrils. However, Hsp110, Hsp70, and Hsp40 exploit the slow monomer exchange dynamics of amyloid, and can slowly depolymerize amyloid fibrils from their ends in a manner that is stimulated by small heat shock proteins. Upregulation of this system could have key therapeutic applications in various protein-misfolding disorders. Intriguingly, yeast Hsp104 can interface with metazoan Hsp110, Hsp70, and Hsp40 to rapidly eliminate disease associated amyloid. Thus, metazoan proteostasis is receptive to augmentation with exogenous disaggregases, which opens a number of therapeutic opportunities.

Indexed as

Protein AggregatesAmyloidAnimalsHSP110 Heat-Shock ProteinsHSP40 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsNeurodegenerative DiseasesProtein Aggregation, PathologicalSolubilityAmyloidHSP110 Heat-Shock ProteinsHSP40 Heat-Shock ProteinsHSP70 Heat-Shock ProteinsProtein AggregatesHsp104Hsp110Hsp70metazoaprotein disaggregation

Identifiers

PMID24401655
PMCPMC4201613
OpenAlexW2050871645

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.